MAPK1 and melanoma: Overexpression of ERK2 due to hyperactivation of MAPK signaling can sensitize only RAS/RAF mutant melanoma, but not RAS/RAF wild-type melanoma, suggesting that cells must maintain tightly regulated MAPK signaling levels, which can promote tumor growth but are not tolerated above a given threshold [33].